Maria Eugenia Riveiro

Title: Maria Eugenia Riveiro: Innovator in Cancer Treatment

Introduction

Maria Eugenia Riveiro is a prominent inventor based in Clichy, France. She has made significant contributions to the field of oncology through her innovative research and development of treatment methods for various types of leukemia and lung cancer. With a total of four patents to her name, Riveiro's work is paving the way for new therapeutic approaches in cancer care.

Latest Patents

Riveiro's latest patents include a method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds. This method involves administering a solid dispersion comprising an amorphous thienotriazolodiazepine compound, which has shown promise in treating these aggressive forms of cancer. Additionally, she has developed a method for treating non-small cell lung cancer and/or small cell lung cancer, which also utilizes thienotriazolodiazepine compounds to provide effective treatment options for patients.

Career Highlights

Throughout her career, Riveiro has worked with notable companies in the pharmaceutical industry, including Oncoethix GmbH and Merck Sharp & Dohme Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Riveiro has collaborated with esteemed colleagues such as Eric Raymond and Kay Noel. These partnerships have enhanced her research efforts and have been instrumental in the development of her innovative treatment methods.

Conclusion

Maria Eugenia Riveiro is a trailblazer in the field of cancer treatment, with her patents reflecting her commitment to improving patient outcomes. Her work continues to inspire advancements in oncology and offers hope for those affected by these challenging diseases.